Table 3 Infant delivery and HIV diagnosis details
From: Patient factors to target for elimination of mother-to-child transmission of HIV
Variable | Cases (n = 77) | Controls (n = 154) | P-value |
|---|---|---|---|
Mode of delivery, n (%) | Â | Â | Â |
 NVD | 48 (62.3) | 106 (68.8) | 0.690 |
 C-section | 29 (37.7) | 46 (29.9) |  |
 Assisted delivery | 0 (0.0) | 2 (1.3) |  |
¥Birth weight (g), median (IQR) | 2850 (2450 – 3100) | 2950 (2600 – 3200) | 0.122 |
Infant antiretroviral prophylaxis, n (%) | Â | Â | Â |
 Prophylaxis received* | 72 (94.7) | 147 (99.3) | 0.030 |
Infant feeding method, n (%) | Â | Â | Â |
 Breastfeeding | 9 (11.7) | 7 (4.6) | 0.044 |
 Formula feeding | 68 (88.3) | 147 (95.4) |  |
Age at 1st HIV test, mean weeks; (SD) | 6.6 (3.5) | 6.0 (0.2) | 0.200 |
Infant age at HIV-positive diagnosis, mean weeks (SD) | 9.0 (4.2) | --- | --- |
Infant age at ART initiation, mean weeks (SD) | 10.8 (4.4) | --- | --- |